Brain Tumor Drug May Help Spur Cancer’s Return
But insights into how that happens may lead to ways around it, researchers say March 5, 2009 RSS Feed Print By Steven Reinberg HealthDay Reporter THURSDAY, March 5 (HealthDay News) — Temozolomide, a standard treatment for brain cancer, may boost the aggressiveness of surviving cancer cells, making tumor recurrence more likely, a new study suggests.…
Details